Danube AG

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam 18:00:00 2024-04-17 EDT 5-day change 1st Jan Change
102.8 CHF +1.13% Intraday chart for Danube AG +1.08% +11.68%
This Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
U.S. Futures Down, European Stocks Mixed DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. CI
DSM-Firmenich AG authorizes a Buyback Plan. CI
DSM-FIRMENICH : A stronger long-term outlook Alphavalue
Quiz sales fall, names new CEO; Byotrol eyes AIM exit AN
Quotes from Dutch companies on the worsening business climate RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc. RE
DSM-Firmenich Completes Sale of Vitamin C Plant in China MT
Jingjiang Cosfocus Health Technology Co., Ltd. acquired DSM Jiangshan Pharmaceutical Co., Ltd from DSM-Firmenich AG. CI
Philips: Chairman to seek second term CF
DSM-FIRMENICH : Some mess from the combination Alphavalue
Global markets live: Airbus, Cisco, BAE, Salesforce, Deere... Our Logo
FTSE 100 Closes Up As Investors Shrug Off Recession Confirmation DJ
DSM-FIRMENICH : An even pure(er) play Alphavalue
DSM-Firmenich Plans to Spinoff Pet Care Business CI
Dsm-firmenich Plans Pharmacokinetic Trial for New Cannabidiol Formulation With Zerion Pharma MT
Transcript : DSM-Firmenich AG, 2023 Earnings Call, Feb 15, 2024
Dsm-firmenich to Carve Out Animal Nutrition Business MT
DSM Firmenich plans to separate animal nutrition and health unit RE
DSM-Firmenich AG Proposes Dividend for the Financial Year 2023 CI
DSM-Firmenich AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Global markets live: TUI, Coca-Cola, Biogen, ARM Holdings, Glencore... Our Logo
DSM-Firmenich Amasses 98.5% Stake in DSM With Voluntary Tender Offer MT
British antitrust watchdog expands investigation into fragrance manufacturers DP
DSM-Firmenich Offers to Expedite Buy-out of Remaining DSM Shares MT
Chart Danube AG
More charts
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
102.8 EUR
Average target price
118.8 EUR
Spread / Average Target
+15.66%
Consensus
  1. Stock Market
  2. Equities
  3. DSFIR Stock
  4. News Danube AG
  5. DSM-Firmenich : Awaiting the recovery